BCM
RVNC

Beryl Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Beryl Capital Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,935,009
Closed -$18M – 34
2024
Q4 		$18M Buy
+5,935,009
New +$18M 4.08% 3